BRIGHTER BITES GUSNIP PRODUCE PRESCRIPTION

The primary goals and objectives of the Brighter bites Produce Prescription Program are to demonstrate and evaluate the impact of this project on:Goal 1: The improvement of dietary health through increased consumption of fruits and vegetables.Objective 1.1, Pediatric Health Outcomes: Improve child health outcomes obtained from chart reviews for the following measures: BMI, blood pressure, hemoglobin A1c, AST, ALT, and lipid panels.Objective 1.2, Adolescent emotional health outcomes: Improve adolescent patient's behavioral and emotional health. Legacy Behavioral Health Therapists will utilize the Patient Health Questionnaire for Adolescents (PHQ-A) in order to evaluate the impact of the Produce Prescription intervention on adolescent patient's behavioral and emotional health.Objective 1.3, Dietary Outcomes: Increased frequency of fruit and vegetable intake, reduced consumption of soda and other sugar-sweetened foods and beverages, increased incidence of meals cooked from scratch. Improve parental dietary intake including fruit and vegetable consumption.Goal 2: The reduction of individual and household food insecurity.Objective 2.1, Household food security and nutrition security: Food security will be measured using the validated two-item Hunger vital sign. Nutrition security will be measured using a four-item validated screener. These items will be self-reported by parents or guardians.Goal 3: The reduction in healthcare use and associated costs.Objective 3.1, Healthcare usage: We will assess healthcare usage and associated costs using tracking data from Legacy, including the number of Well-visits and the number of visits due to illness during the 6 months prior to the intervention, during the intervention, and one-month post-intervention.Objective 3.2, Healthcare usage long-term: Legacy clinicians will also collect and share data from pediatric patients' pre- and post-program annual well-visits, including BMI percentiles, weight, blood pressure, and hemoglobin A1c, ALT, AST, and lipids, demonstrating an improvement in health markers, which can contribute to decreased healthcare utilization and associated costs long-term.